Ubiquitin-conjugating enzyme UBE2Q2 participates in HUWE1-mediated protection on renal tubulointerstitial fibrosis.
- Author:
Zheng WANG
1
;
Hao DONG
1
;
Min LI
2
;
Xiu-Bin LIANG
3
Author Information
1. Department of Pathophysiology, Nanjing Medical University, Nanjing 211166, China.
2. Department of Pathology, Nanjing Medical University, Nanjing 211166, China.
3. Department of Pathophysiology, Nanjing Medical University, Nanjing 211166, China. liangxiubin@njmu.edu.cn.
- Publication Type:Journal Article
- MeSH:
Animals;
Cell Line;
Fibrosis;
Humans;
Kidney Diseases;
Mice;
Ubiquitin-Conjugating Enzymes/metabolism*;
Ubiquitin-Protein Ligases/metabolism*;
Ubiquitination
- From:
Acta Physiologica Sinica
2022;74(1):117-124
- CountryChina
- Language:Chinese
-
Abstract:
The ubiquitin-proteasome system plays an important role in protein degradation. The process of ubiquitination requires ubiquitin activating enzyme E1, ubiquitin-conjugating enzyme E2, and ubiquitin ligase E3 to complete the coordination. Our previous studies have shown that HUWE1 (HECT, UBA and WWE domain containing 1), as an E3 ubiquitin ligase, can degrade epidermal growth factor receptor (EGFR) to inhibit renal tubulointerstitial fibrosis. However, E2 ubiquitin-conjugating enzymes binding to HUWE1 are still unclear. The aim of the present study was to identify E2 ubiquitin-conjugating enzymes of HUWE1. Real-time PCR was used to identify E2 ubiquitin-conjugating enzyme that may interact with HUWE1. The expression of E2 ubiquitin-conjugating enzyme was detected in kidney of unilateral ureteral obstruction (UUO) mice and HK-2 cells treated with transforming growth factor-β (TGF-β). The results showed that the expressions of E2 ubiquitin-conjugating enzyme UBE2Q2 were significantly down-regulated at both RNA and protein levels in UUO kidneys. The expression of UBE2Q2 was also down-regulated in HK-2 cells stimulated with TGF-β, which was consistent with the change in the expression of HUWE1. These findings indicated that UBE2Q2 expression was synergistic with HUWE1 in the injured kidney. Co-immunoprecipitation (Co-IP) experiments showed that HUWE1 interacted with UBE2Q2 in HK-2 cells. The co-localization of UBE2Q2 and HUWE1 was confirmed by cell immunofluorescence staining. After knocking down UBE2Q2 by siRNA, ubiquitin binding to HUWE1 and EGFR was decreased. In sum, our results demonstrated that UBE2Q2, ubiquitin-conjugating enzyme, works with HUWE1 to mediate ubiquitination and degradation of target protein in kidney.
